Panel Ecosystem Innovation track
Open Innovation in Action: How Pharma Is Rewiring the Drug Discovery Ecosystem
Mon, Nov 9, 2026 · 1:00–1:45 PM CET Ecosystem Innovation Stage, Koelnmesse
About this session
The traditional boundaries of drug discovery are dissolving. Increasingly, pharmaceutical companies are opening their compound libraries, data, and expertise to the global research community through open innovation platforms. Initiatives such as opnMe from Boehringer Ingelheim are reshaping how early scientific ideas move from academia and biotech into the pharmaceutical pipeline.
Speakers
-
Director, Neurology & Immunology, Business Development & AI Strategy and Enablement Lead · Merck KGaA
Panelist
